Evaluated by: David B. Kaminsky, M.D., FIAC, March 21, 2018
Original release date: May 29, 2018
Access to this course expires on: March 21, 2021
Faculty: Michael Roh, M.D., Ph.D.
- To understand the scope of use of cytologic specimen material for molecular studies.
- To understand preanalytical specimen requirements for screening and targeted methods of molecular testing.
- To understand the use of targeted therapy for lung adenocarcinomas based on molecular mutational events identified.
- To identify the most common mutation in BRAF in the context of malignant melanoma.
$59.00 - $79.00